These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30907134)

  • 41. The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease.
    Martinez Velazquez LA; Ballios BG
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene therapy for the eye focus on mutation-independent approaches.
    Dalkara D; Duebel J; Sahel JA
    Curr Opin Neurol; 2015 Feb; 28(1):51-60. PubMed ID: 25545056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bipolar cell targeted optogenetic gene therapy restores parallel retinal signaling and high-level vision in the degenerated retina.
    Kralik J; van Wyk M; Stocker N; Kleinlogel S
    Commun Biol; 2022 Oct; 5(1):1116. PubMed ID: 36266533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene Therapy for Retinal Degeneration.
    Apte RS
    Cell; 2018 Mar; 173(1):5. PubMed ID: 29570997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optogenetics, visual prosthesis and electrostimulation for retinal dystrophies.
    Garg SJ; Federman J
    Curr Opin Ophthalmol; 2013 Sep; 24(5):407-14. PubMed ID: 23799487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optogenetic approaches to treat epilepsy.
    Wykes RC; Kullmann DM; Pavlov I; Magloire V
    J Neurosci Methods; 2016 Feb; 260():215-20. PubMed ID: 26072246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optogenetic approaches to study the mammalian brain.
    Deubner J; Coulon P; Diester I
    Curr Opin Struct Biol; 2019 Aug; 57():157-163. PubMed ID: 31082625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optogenetic Vision Restoration Using Rhodopsin for Enhanced Sensitivity.
    Gaub BM; Berry MH; Holt AE; Isacoff EY; Flannery JG
    Mol Ther; 2015 Oct; 23(10):1562-71. PubMed ID: 26137852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
    Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensitization of ON-bipolar cells with ambient light activatable multi-characteristic opsin rescues vision in mice.
    Batabyal S; Gajjeraman S; Pradhan S; Bhattacharya S; Wright W; Mohanty S
    Gene Ther; 2021 Apr; 28(3-4):162-176. PubMed ID: 33087861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene therapy for retinal degeneration.
    Reichel MB; Ali RR; Hunt DM; Bhattacharya SS
    Ophthalmic Res; 1997; 29(5):261-8. PubMed ID: 9323717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Innovative Optogenetic Strategies for Vision Restoration.
    Baker CK; Flannery JG
    Front Cell Neurosci; 2018; 12():316. PubMed ID: 30297985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Layer-specific nanophotonic delivery of therapeutic opsin-encoding genes into retina.
    Batabyal S; Kim S; Wright W; Mohanty S
    Exp Eye Res; 2021 Apr; 205():108444. PubMed ID: 33516760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging Approaches for Restoration of Hearing and Vision.
    Kleinlogel S; Vogl C; Jeschke M; Neef J; Moser T
    Physiol Rev; 2020 Oct; 100(4):1467-1525. PubMed ID: 32191560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optogenetic therapy: high spatiotemporal resolution and pattern discrimination compatible with vision restoration in non-human primates.
    Gauvain G; Akolkar H; Chaffiol A; Arcizet F; Khoei MA; Desrosiers M; Jaillard C; Caplette R; Marre O; Bertin S; Fovet CM; Demilly J; Forster V; Brazhnikova E; Hantraye P; Pouget P; Douar A; Pruneau D; Chavas J; Sahel JA; Dalkara D; Duebel J; Benosman R; Picaud S
    Commun Biol; 2021 Jan; 4(1):125. PubMed ID: 33504896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biophysical Properties of Optogenetic Tools and Their Application for Vision Restoration Approaches.
    Klapper SD; Swiersy A; Bamberg E; Busskamp V
    Front Syst Neurosci; 2016; 10():74. PubMed ID: 27642278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined Optogenetic and Chemogenetic Control of Neurons.
    Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U
    Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Restoring vision in mice with retinal degeneration using multicharacteristic opsin.
    Wright W; Gajjeraman S; Batabyal S; Pradhan S; Bhattacharya S; Mahapatra V; Tripathy A; Mohanty S
    Neurophotonics; 2017 Oct; 4(4):041412. PubMed ID: 28840163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene therapy for inherited retinal degenerations: initial successes and future challenges.
    Gupta PR; Huckfeldt RM
    J Neural Eng; 2017 Oct; 14(5):051002. PubMed ID: 28829759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retinal optogenetic therapies: clinical criteria for candidacy.
    Jacobson SG; Sumaroka A; Luo X; Cideciyan AV
    Clin Genet; 2013 Aug; 84(2):175-82. PubMed ID: 23590195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.